Compare Howmet Aerospace Inc (HWM) vs Nuvalent Inc (NUVL) Price & Performance

Howmet Aerospace (HWM) trades at $271.98, down 0.17% on the day, with technical indicators showing a neutral trend. The company demonstrates strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.22 beating expectations of $1.11, and robust profitability with a 20.22% net income margin. Recent news highlights strength in commercial aerospace demand driving growth prospects.

The outlook remains positive with 84% analyst buy ratings and a $317.63 consensus price target implying 17% upside. Key risks include premium valuation multiples and exposure to aerospace cycle volatility. Continued execution on commercial aerospace growth and defense contracts supports the bullish case, though investors should monitor Q2 2026 earnings due August 6 for confirmation.

Nuvalent (NUVL) trades at $123.96, showing no change recently, with technical indicators presenting a mixed signal—moving averages are bullish while oscillators are bearish. The company reported a net loss of $425.38 million for 2025, with negative profitability metrics like ROE of -41.19%. Recent news highlights GSK's proposed acquisition of Nuvalent for $124 per share, totaling $10.6 billion, which is under investigation by multiple law firms for fairness concerns.

The investment outlook is heavily influenced by the pending acquisition, offering a near-term exit at $124 per share. However, risks include ongoing financial losses, negative cash flow from operations, and legal scrutiny over the deal's adequacy. Analyst sentiment is mixed with 42% buy ratings, but the acquisition provides a clear valuation anchor amid fundamental challenges.